LifeMD, Inc. — Director's Dealing 2017

Nov 8, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: Aldridge Ryan (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option	$0.2	2027-02-01	Common Stock, par value $0.01 (500000)		Direct
Warrant	$0.2	2019-09-21	Common Stock, par value $0.01 (50000)		Direct
Warrant	$0.5	2019-09-21	Common Stock, par value $0.01 (50000)		Direct